Brief News Fresenius Kabi enters collaboration to enhance controlled substance management in the U.S. Fresenius Kabi and Omnicell, Inc are collaborating to provide U.S. hospitals and health systems with innovative new pharmacy technology designed to support safety and efficiency in dispensing of controlled substances in patient care areas..